An advanced practice provider–led weight intervention pathway was more successful in achieving weight loss in patients with nonalcoholic fatty liver disease than standard hepatology care, according to a study presented at the 2021 Liver Meeting.
Clinical trials in targeted weight loss for patients with nonalcoholic steatohepatitis have shown that a minority reach the 5% reduction (30% of patients) or 10% reduction (10% of patients) in total body weight recommended by the American